Back
Pliant Therapeutics Vs. Akero Therapeutics Industry Stock Comparison
Sell
37
PLRX
Pliant Therapeutics
Last Price:
$1.35
Seasonality Move:
44.98%
Buy
62
AKRO
Akero Therapeutics
Last Price:
$49.64
Seasonality Move:
22.68%
Sell
37
Pliant Therapeutics (PLRX)
is a Sell
Is Pliant Therapeutics a Buy, Sell or Hold?
-
The current Pliant Therapeutics [PLRX] share price is $1.35. The Score for PLRX is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
-
PLRX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
62
Akero Therapeutics (AKRO)
is a Buy
Is Akero Therapeutics a Buy, Sell or Hold?
-
The current Akero Therapeutics [AKRO] share price is $49.65. The Score for AKRO is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
-
AKRO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PLRX Stock Price Chart
What is Pliant Therapeutics's stock price today?
-
The Pliant Therapeutics share price today is $1.35Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PLRX is experiencing slight selling pressure.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $49.65Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKRO is experiencing slight buying pressure.
PLRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.08 | Sell |
| Relative Strength Index (14 RSI): | 42.39 | Sell |
| Chaikin Money Flow: | -156891 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.32 - 1.52) | Sell |
| Bollinger Bands (100): | (-0.15 - 8.53) | Sell |
AKRO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.8 | Buy |
| Relative Strength Index (14 RSI): | 63.34 | Buy |
| Chaikin Money Flow: | 338672 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (40.2 - 47.04) | Buy |
| Bollinger Bands (100): | (33.25 - 50.45) | Buy |
PLRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.34 | Buy |
| 20-day SMA: | 1.4 | Sell |
| 50-day SMA: | 1.43 | Sell |
| 200-day SMA: | 8.7 | Sell |
| 8-day EMA: | 1.35 | Buy |
| 20-day EMA: | 1.39 | Sell |
| 50-day EMA: | 2.01 | Sell |
| 200-day EMA: | 7.14 | Sell |
AKRO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 47.53 | Buy |
| 20-day SMA: | 43.67 | Buy |
| 50-day SMA: | 41.67 | Buy |
| 200-day SMA: | 35.37 | Buy |
| 8-day EMA: | 46.63 | Buy |
| 20-day EMA: | 44.43 | Buy |
| 50-day EMA: | 42.76 | Buy |
| 200-day EMA: | 36.98 | Buy |
Pliant Therapeutics Earnings Growth & PLRX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.50 per share, a decrease next quarter of $0.13 per share, an increase this year of $1.09 per share, and an increase next year of $0.08 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.16 per share, and a decrease next year of $0.63 per share.
Pliant Therapeutics Technical Analysis
| May 16 | May 19 | May 20 | May 21 | May 22 | May 23 | May 27 | May 28 | May 29 | May 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 16 | 19 | 20 | 21 | 22 | 23 | 27 | 28 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Akero Therapeutics Technical Analysis
| May 16 | May 19 | May 20 | May 21 | May 22 | May 23 | May 27 | May 28 | May 29 | May 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 16 | 19 | 20 | 21 | 22 | 23 | 27 | 28 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||